annual ROE:
-26.84%+10.61%(+28.33%)Summary
- As of today (September 17, 2025), CLDX annual return on equity is -26.84%, with the most recent change of +10.61% (+28.33%) on December 31, 2024.
- During the last 3 years, CLDX annual ROE has fallen by -4.41% (-19.66%).
- CLDX annual ROE is now -123.62% below its all-time high of 113.63%, reached on December 31, 2007.
Performance
CLDX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly ROE:
-26.94%-3.94%(-17.13%)Summary
- As of today (September 17, 2025), CLDX quarterly return on equity is -26.94%, with the most recent change of -3.94% (-17.13%) on June 1, 2025.
- Over the past year, CLDX quarterly ROE has increased by +1.88% (+6.52%).
- CLDX quarterly ROE is now -116.04% below its all-time high of 168.00%, reached on April 30, 1986.
Performance
CLDX quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CLDX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +28.3% | +6.5% |
| 3 y3 years | -19.7% | +2.6% |
| 5 y5 years | +42.5% | +25.8% |
CLDX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -19.7% | +28.3% | -23.4% | +39.7% |
| 5 y | 5-year | -19.7% | +42.5% | -23.4% | +39.7% |
| alltime | all time | -123.6% | +93.5% | -116.0% | +96.9% |
CLDX ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -26.94%(+17.1%) |
| Mar 2025 | - | -23.00%(+5.3%) |
| Dec 2024 | -26.84%(-28.3%) | -21.84%(-11.7%) |
| Sep 2024 | - | -24.74%(-14.2%) |
| Jun 2024 | - | -28.82%(-16.7%) |
| Mar 2024 | - | -34.58%(-22.6%) |
| Dec 2023 | -37.45%(+24.3%) | -44.69%(+7.5%) |
| Sep 2023 | - | -41.58%(+18.9%) |
| Jun 2023 | - | -34.98%(+2.5%) |
| Mar 2023 | - | -34.14%(+12.7%) |
| Dec 2022 | -30.13%(+34.3%) | -30.29%(+12.3%) |
| Sep 2022 | - | -26.97%(-2.5%) |
| Jun 2022 | - | -27.66%(+17.1%) |
| Mar 2022 | - | -23.62%(-3.4%) |
| Dec 2021 | -22.43%(-43.1%) | -24.45%(-15.3%) |
| Sep 2021 | - | -28.85%(-7.9%) |
| Jun 2021 | - | -31.32%(-6.0%) |
| Mar 2021 | - | -33.32%(-4.6%) |
| Dec 2020 | -39.41%(-15.5%) | -34.94%(+8.1%) |
| Sep 2020 | - | -32.32%(-10.9%) |
| Jun 2020 | - | -36.29%(-21.3%) |
| Mar 2020 | - | -46.13%(-1.7%) |
| Dec 2019 | -46.66%(-44.4%) | -46.95%(+8.5%) |
| Sep 2019 | - | -43.27%(+14.2%) |
| Jun 2019 | - | -37.89%(-5.5%) |
| Mar 2019 | - | -40.10%(-60.2%) |
| Dec 2018 | -83.89%(+126.2%) | -100.70%(+17.0%) |
| Sep 2018 | - | -86.09%(-0.8%) |
| Jun 2018 | - | -86.79%(+4.9%) |
| Mar 2018 | - | -82.75%(+113.5%) |
| Dec 2017 | -37.08%(-19.9%) | -38.76%(-24.7%) |
| Sep 2017 | - | -51.44%(-1.3%) |
| Jun 2017 | - | -52.12%(-0.3%) |
| Mar 2017 | - | -52.29%(+3.1%) |
| Dec 2016 | -46.27%(-8.7%) | -50.71%(+3.9%) |
| Sep 2016 | - | -48.81%(+7.8%) |
| Jun 2016 | - | -45.29%(+9.4%) |
| Mar 2016 | - | -41.41%(+0.4%) |
| Dec 2015 | -50.70%(+14.1%) | -41.25%(-2.6%) |
| Sep 2015 | - | -42.36%(-0.5%) |
| Jun 2015 | - | -42.58%(-0.4%) |
| Mar 2015 | - | -42.76%(-3.8%) |
| Dec 2014 | -44.44%(+13.2%) | -44.46%(+4.5%) |
| Sep 2014 | - | -42.54%(-0.4%) |
| Jun 2014 | - | -42.69%(+3.4%) |
| Mar 2014 | - | -41.27%(-4.4%) |
| Dec 2013 | -39.25%(-45.4%) | -43.18%(-19.0%) |
| Sep 2013 | - | -53.31%(+2.2%) |
| Jun 2013 | - | -52.18%(-3.1%) |
| Mar 2013 | - | -53.87%(-16.5%) |
| Dec 2012 | -71.88%(+15.5%) | -64.55%(+3.9%) |
| Sep 2012 | - | -62.15%(+6.5%) |
| Jun 2012 | - | -58.35%(+0.4%) |
| Mar 2012 | - | -58.13%(-0.8%) |
| Dec 2011 | -62.23%(+1730.3%) | -58.57%(+355.4%) |
| Sep 2011 | - | -12.86%(+32.0%) |
| Jun 2011 | - | -9.74%(+4.2%) |
| Mar 2011 | - | -9.35%(+143.5%) |
| Dec 2010 | -3.40%(-95.7%) | -3.84%(-95.0%) |
| Sep 2010 | - | -76.72%(-14.7%) |
| Jun 2010 | - | -89.95%(-21.9%) |
| Mar 2010 | - | -115.11%(-34.3%) |
| Dec 2009 | -79.49%(-69.7%) | -175.19%(-37.0%) |
| Sep 2009 | - | -277.98%(+54.3%) |
| Jun 2009 | - | -180.11%(+21.3%) |
| Mar 2009 | - | -148.50%(-49.7%) |
| Dec 2008 | -261.95%(-330.5%) | -294.95%(-9.5%) |
| Sep 2008 | - | -325.96%(-11.3%) |
| Jun 2008 | - | -367.62%(-57.8%) |
| Mar 2008 | - | -871.48%(-866.9%) |
| Dec 2007 | 113.63%(-164.3%) | 113.63%(-114.4%) |
| Sep 2007 | - | -789.29%(+221.9%) |
| Jun 2007 | - | -245.20%(+16.8%) |
| Mar 2007 | - | -209.90%(+27.2%) |
| Dec 2006 | -176.78%(+189.6%) | -165.01%(+53.3%) |
| Sep 2006 | - | -107.65%(+32.7%) |
| Jun 2006 | - | -81.12%(+26.7%) |
| Mar 2006 | - | -64.04%(+3.8%) |
| Dec 2005 | -61.04% | -61.68%(+16.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2005 | - | -53.09%(+17.8%) |
| Jun 2005 | - | -45.05%(+16.5%) |
| Mar 2005 | - | -38.67%(+19.1%) |
| Dec 2004 | -39.81%(+2.6%) | -32.48%(+3.6%) |
| Sep 2004 | - | -31.35%(+4.6%) |
| Jun 2004 | - | -29.96%(-3.4%) |
| Mar 2004 | - | -31.02%(-22.4%) |
| Dec 2003 | -38.79%(+7.5%) | -39.97%(-0.7%) |
| Sep 2003 | - | -40.24%(+20.4%) |
| Jun 2003 | - | -33.41%(-7.6%) |
| Mar 2003 | - | -36.16%(-2.1%) |
| Dec 2002 | -36.10%(-21.3%) | -36.95%(-16.6%) |
| Sep 2002 | - | -44.28%(-21.9%) |
| Jun 2002 | - | -56.72%(+5.1%) |
| Mar 2002 | - | -53.97%(+10.4%) |
| Dec 2001 | -45.87%(-25.5%) | -48.88%(-22.1%) |
| Sep 2001 | - | -62.72%(+16.1%) |
| Jun 2001 | - | -54.00%(+17.9%) |
| Mar 2001 | - | -45.81%(+12.4%) |
| Dec 2000 | -61.60%(-1.5%) | -40.75%(-16.3%) |
| Sep 2000 | - | -48.70%(+14.3%) |
| Jun 2000 | - | -42.61%(+3.2%) |
| Mar 2000 | - | -41.28%(-6.2%) |
| Dec 1999 | -62.51%(-84.9%) | -44.01%(-20.0%) |
| Sep 1999 | - | -55.03%(-84.4%) |
| Jun 1999 | - | -353.20%(-4.8%) |
| Mar 1999 | - | -370.92%(-0.5%) |
| Dec 1998 | -412.99%(+245.5%) | -372.86%(-25.7%) |
| Sep 1998 | - | -501.97%(+243.2%) |
| Jun 1998 | - | -146.28%(+12.2%) |
| Mar 1998 | - | -130.43%(+10.1%) |
| Dec 1997 | -119.52%(+75.1%) | -118.44%(+13.4%) |
| Sep 1997 | - | -104.48%(+75.0%) |
| Jun 1997 | - | -59.71%(-21.4%) |
| Mar 1997 | - | -76.01%(+3.2%) |
| Dec 1996 | -68.25%(+38.8%) | -73.65%(+15.3%) |
| Sep 1996 | - | -63.88%(-15.7%) |
| Jun 1996 | - | -75.76%(+31.5%) |
| Mar 1996 | - | -57.61%(-1.3%) |
| Dec 1995 | -49.17%(-1.0%) | -58.37%(-29.1%) |
| Sep 1995 | - | -82.35%(+19.4%) |
| Jun 1995 | - | -68.97%(+18.3%) |
| Mar 1995 | - | -58.29%(+18.3%) |
| Dec 1994 | -49.68%(+56.4%) | -49.28%(+20.0%) |
| Sep 1994 | - | -41.08%(+3.0%) |
| Jun 1994 | - | -39.89%(+4.6%) |
| Mar 1994 | - | -38.13%(-2.5%) |
| Dec 1993 | -31.77%(+92.4%) | -39.12%(+8.7%) |
| Sep 1993 | - | -35.98%(+34.0%) |
| Jun 1993 | - | -26.86%(+10.3%) |
| Mar 1993 | - | -24.35%(+40.3%) |
| Dec 1992 | -16.51%(-39.0%) | - |
| Oct 1992 | - | -17.36%(-4.5%) |
| Jul 1992 | - | -18.17%(-11.8%) |
| Apr 1992 | - | -20.59%(-0.9%) |
| Apr 1992 | -27.06%(-6.5%) | - |
| Jan 1992 | - | -20.77%(-21.6%) |
| Oct 1991 | - | -26.50%(+2.4%) |
| Jul 1991 | - | -25.87%(-12.3%) |
| Apr 1991 | -28.94%(+211.2%) | -29.51%(+53.2%) |
| Jan 1991 | - | -19.26%(+60.0%) |
| Oct 1990 | - | -12.04%(+0.6%) |
| Jul 1990 | - | -11.97%(+37.6%) |
| Apr 1990 | -9.30%(-25.2%) | -8.70%(-33.6%) |
| Jan 1990 | - | -13.11%(-35.2%) |
| Oct 1989 | - | -20.24%(+21.4%) |
| Jul 1989 | - | -16.67%(-3.0%) |
| Apr 1989 | -12.43%(+2.1%) | -17.19%(+6.6%) |
| Jan 1989 | - | -16.13%(+15.4%) |
| Oct 1988 | - | -13.98%(+18.2%) |
| Jul 1988 | - | -11.83%(-43.5%) |
| Apr 1988 | -12.18%(-39.9%) | -20.93%(+81.4%) |
| Jan 1988 | - | -11.54%(+20.0%) |
| Oct 1987 | - | -9.62%(+11.2%) |
| Jul 1987 | - | -8.65%(+12.5%) |
| Apr 1987 | -20.25%(-129.8%) | -7.69%(-105.7%) |
| Jan 1987 | - | 136.00%(-12.8%) |
| Oct 1986 | - | 156.00%(-7.1%) |
| Jul 1986 | - | 168.00%(0.0%) |
| Apr 1986 | 68.00% | 168.00% |
FAQ
- What is Celldex Therapeutics, Inc. annual return on equity?
- What is the all time high annual ROE for Celldex Therapeutics, Inc.?
- What is Celldex Therapeutics, Inc. annual ROE year-on-year change?
- What is Celldex Therapeutics, Inc. quarterly return on equity?
- What is the all time high quarterly ROE for Celldex Therapeutics, Inc.?
- What is Celldex Therapeutics, Inc. quarterly ROE year-on-year change?
What is Celldex Therapeutics, Inc. annual return on equity?
The current annual ROE of CLDX is -26.84%
What is the all time high annual ROE for Celldex Therapeutics, Inc.?
Celldex Therapeutics, Inc. all-time high annual return on equity is 113.63%
What is Celldex Therapeutics, Inc. annual ROE year-on-year change?
Over the past year, CLDX annual return on equity has changed by +10.61% (+28.33%)
What is Celldex Therapeutics, Inc. quarterly return on equity?
The current quarterly ROE of CLDX is -26.94%
What is the all time high quarterly ROE for Celldex Therapeutics, Inc.?
Celldex Therapeutics, Inc. all-time high quarterly return on equity is 168.00%
What is Celldex Therapeutics, Inc. quarterly ROE year-on-year change?
Over the past year, CLDX quarterly return on equity has changed by +1.88% (+6.52%)